XML 68 R38.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity (Tables)
12 Months Ended
Dec. 31, 2024
Equity  
Schedule of the activity related to the Company's restricted stock and restricted stock unit awards

    

    

Weighted-Average

Shares/Units

Grant Fair Value

Unvested at August 1, 2024

$

$

Granted

426,980

27.24

Vested

(39,407)

28.27

Forfeited

(8,158)

26.47

Unvested at December 31, 2024

$

379,415

$

27.14

Schedule of assumptions used to calculate grant date fair value of awards

    

December 31, 2024

Weighted-average fair value

$

14.46

Dividend yield

0%

Expected volatility of stock

55% to 58%

Risk-free interest rate

3.9% to 4.0%

Expected option life (in years)

6.5 to 7.5

Weighted-average exercise price per share

$

35.93

Schedule of the activity related to the Company's non-qualified stock options

    

    

Weighted-Average

    

Weighted-Average

Remaining Contractual

Aggregate Intrinsic

Options

    

Exercise Price

    

Life (years)

    

Value (in thousands)

Outstanding at August 1, 2024

$

$

Granted

478,419

35.93

9.33

489

Exercised

Forfeited or expired

Outstanding at December 31, 2024

478,419

$

35.93

9.33

$

489

Exercisable

14,964

119.60

1.41

Schedule of location of stock-based compensation expense in the condensed consolidated statements of operations

Year Ended December 31, 

in thousands

   

2024

   

2023

   

2022

Expenses

Sponsorships, events, and entertainment costs

$

647

$

528

$

350

Hospitality costs

100

130

19

Operating costs

(504)

837

500

General and administrative

3,095

Total stock-based compensation expense

$

3,338

$

1,495

$

869

Schedule of earnings per share

    

Year Ended December 31, 

in thousands, except per share data

    

2024

    

2023

   

2022

Numerator - Basic

Net loss

$

(152,625)

$

(838,065)

$

(111,277)

Preferred distributions to noncontrolling interest in subsidiary

(587)

Net loss attributable to common stockholders - basic and diluted

$

(153,212)

$

(838,065)

$

(111,277)

Denominator

Weighted average shares outstanding - basic

9,108

5,522

5,522

Effect of dilutive securities

Weighted average shares outstanding - diluted

9,108

5,522

5,522

Earnings (loss) per share - basic and dilutive

$

(16.82)

$

(151.77)

$

(20.15)

Schedule of shares excluded from the calculation of diluted earnings per share

    

Year Ended December 31, 

    

2024

    

2023

   

2022

Shares issuable upon exercise of restricted stock and restricted stock units

209,790

35,101

35,101

Shares issuable upon exercise of stock options

16,437

8,501

8,501